Shionogi Pharma Set to Expand CDMO Biz with Continuous Manufacturing, Eyes 10 Billion Yen Sales in FY2024

Shionogi Pharma’s Settsu Factory (Courtesy of Shionogi Pharma) Shionogi Pharma, a manufacturing subsidiary of Shionogi, will leverage its strengths in continuous manufacturing (CM) to grow its CDMO business. In December, its parent filed an application seeking to introduce CM for...read more